Barbara Gayle Duncan - Director at Atea Pharmaceuticals, Inc.
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Director
- Issuer Symbol
- AVIR on Nasdaq
- All Insider Reports
- All Insider Reports
There are no Buy or Sell transactions made by Barbara Gayle Duncan since 06 Apr 2025
Holdings reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.
| Security | Num Shares | Value | Price $ | Transaction Date | Ownership | Underlying Class | Underlying Amount |
|---|---|---|---|---|---|---|---|
| Common Stock | 62,750 | $176,327 | $2.81 | 20 Jun 2025 | Direct | ||
| Restricted Stock Units | 0 | $103,162 | $3.49 | 20 Jun 2025 | Direct | Common Stock | |
| Stock Option (Right to Buy) | 41,200 | 20 Jun 2025 | Direct | Common Stock |
Transactions reported by Barbara Gayle Duncan for Atea Pharmaceuticals, Inc.
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.